AlloCAR70-NKT cells exhibited robust cytotoxic activity and multimodal tumor-targeting across a diverse panel of established RCC cell lines and primary patient-derived RCC tumor cells with heterogeneous CD70 expression, both in vitro and in vivo (Figures 3, 4, 5, and S3). Here, CD70 is linked to neoplasm.